See more : Feutune Light Acquisition Corporation (FLFVR) Income Statement Analysis – Financial Results
Complete financial analysis of Albert David Limited (ALBERTDAVD.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Albert David Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Daekyo Co., Ltd. (019680.KS) Income Statement Analysis – Financial Results
- American Seniors Association Holding Group, Inc. (AMSA) Income Statement Analysis – Financial Results
- Krynica Vitamin S.A. (KVT.WA) Income Statement Analysis – Financial Results
- Boston Omaha Corporation (BOC) Income Statement Analysis – Financial Results
- AP Acquisition Corp. (APCA-WT) Income Statement Analysis – Financial Results
Albert David Limited (ALBERTDAVD.NS)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.albertdavidindia.com
About Albert David Limited
Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, bulk drugs, and disposable syringes and needles in India. It offers formulations for parenterals, oral/enteral, topical agents, and vision care products. The company also exports its products to Latin American, Southeast Asian, and other African countries. The company was incorporated in 1938 and is headquartered in Kolkata, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.62B | 3.42B | 3.12B | 2.46B | 3.18B | 3.13B | 2.88B | 3.03B | 3.21B | 3.20B | 2.90B | 2.63B | 2.31B | 2.18B | 2.03B | 1.84B | 1.58B |
| Cost of Revenue | 1.28B | 1.23B | 1.18B | 880.25M | 1.08B | 1.10B | 936.41M | 927.47M | 1.08B | 1.13B | 1.10B | 974.10M | 778.41M | 728.08M | 699.00M | 637.61M | 539.91M |
| Gross Profit | 2.34B | 2.18B | 1.95B | 1.58B | 2.10B | 2.03B | 1.94B | 2.11B | 2.13B | 2.08B | 1.80B | 1.65B | 1.53B | 1.46B | 1.33B | 1.20B | 1.04B |
| Gross Profit Ratio | 64.58% | 63.96% | 62.39% | 64.26% | 66.09% | 64.93% | 67.44% | 69.42% | 66.40% | 64.85% | 62.20% | 62.92% | 66.32% | 66.68% | 65.56% | 65.33% | 65.85% |
| Research & Development | 19.49M | 18.96M | 16.01M | 15.26M | 16.37M | 25.76M | 27.01M | 26.20M | 28.84M | 39.44M | 43.40M | 24.69M | 0.00 | 5.77M | 4.28M | 3.52M | 5.23M |
| General & Administrative | 891.44M | 497.35M | 355.62M | 289.41M | 434.55M | 375.62M | 375.31M | 389.76M | 346.39M | 332.41M | 299.66M | 320.82M | 0.00 | 68.76M | 61.04M | 69.92M | 59.53M |
| Selling & Marketing | 115.21M | 166.71M | 158.57M | 111.26M | 176.35M | 196.71M | 185.91M | 245.53M | 260.93M | 263.51M | 203.31M | 195.32M | 0.00 | 198.14M | 183.47M | 164.85M | 142.04M |
| SG&A | 1.01B | 664.06M | 514.19M | 400.67M | 610.91M | 572.33M | 561.22M | 635.29M | 607.32M | 595.92M | 502.97M | 516.14M | 0.00 | 266.89M | 244.51M | 234.77M | 201.57M |
| Other Expenses | 0.00 | 153.96M | 9.79M | 8.01M | 25.17M | 7.64M | 3.06M | 23.37M | 7.92M | 8.11M | 2.06M | 2.37M | 1.93M | 1.00B | 887.36M | 787.42M | 680.03M |
| Operating Expenses | 1.03B | 1.83B | 1.63B | 1.47B | 1.84B | 1.80B | 1.78B | 1.93B | 1.91B | 1.86B | 1.58B | 1.49B | 1.39B | 1.27B | 1.14B | 1.03B | 886.83M |
| Cost & Expenses | 2.29B | 3.06B | 2.80B | 2.35B | 2.92B | 2.89B | 2.72B | 2.86B | 2.98B | 2.99B | 2.68B | 2.46B | 2.17B | 2.00B | 1.84B | 1.66B | 1.43B |
| Interest Income | 40.74M | 33.23M | 34.39M | 31.65M | 15.56M | 18.61M | 13.60M | 9.70M | 2.20M | 2.26M | 2.11M | 1.87M | 1.71M | 2.49M | 1.84M | 1.48M | 1.22M |
| Interest Expense | 4.32M | 4.56M | 3.93M | 5.65M | 6.37M | 3.91M | 4.49M | 5.62M | 16.50M | 24.70M | 32.29M | 29.67M | 25.13M | 26.48M | 38.35M | 51.51M | 38.35M |
| Depreciation & Amortization | 68.25M | 85.48M | 88.06M | 82.32M | 76.75M | 69.78M | 82.31M | 75.17M | 89.99M | 154.15M | 110.57M | 107.35M | 97.76M | 99.64M | 90.48M | 79.52M | 67.33M |
| EBITDA | 1.05B | 598.68M | 567.76M | 364.59M | 376.14M | 366.90M | 307.82M | 356.53M | 740.71M | 386.76M | 334.19M | 272.52M | 236.66M | 290.19M | 286.00M | 248.23M | 220.63M |
| EBITDA Ratio | 28.84% | 17.49% | 14.47% | 9.36% | 12.72% | 11.08% | 8.40% | 9.33% | 10.23% | 11.95% | 11.31% | 10.31% | 10.37% | 13.30% | 14.14% | 13.76% | 14.24% |
| Operating Income | 1.33B | 362.36M | 319.89M | 109.17M | 261.46M | 227.63M | 157.33M | 202.47M | 630.19M | 202.69M | 184.61M | 133.85M | 112.39M | 164.07M | 157.16M | 121.85M | 119.26M |
| Operating Income Ratio | 36.82% | 10.61% | 10.24% | 4.43% | 8.21% | 7.28% | 5.47% | 6.68% | 19.64% | 6.32% | 6.37% | 5.09% | 4.86% | 7.51% | 7.74% | 6.63% | 7.54% |
| Total Other Income/Expenses | -361.60M | -758.15M | -561.33M | -436.12M | 24.98M | 53.93M | 58.11M | 69.88M | -633.32M | -4.87M | 0.00 | -35.88M | 0.00 | 0.00 | 0.00 | -4.64M | -4.30M |
| Income Before Tax | 972.85M | 507.35M | 472.98M | 274.44M | 289.54M | 288.51M | 215.44M | 202.47M | 630.19M | 202.69M | 184.61M | 133.85M | 112.39M | 164.07M | 157.16M | 121.85M | 119.26M |
| Income Before Tax Ratio | 26.84% | 14.85% | 15.14% | 11.14% | 9.09% | 9.23% | 7.49% | 6.68% | 19.64% | 6.32% | 6.37% | 5.09% | 4.86% | 7.51% | 7.74% | 6.63% | 7.54% |
| Income Tax Expense | 218.65M | 145.61M | 120.39M | 53.01M | 97.86M | 111.27M | 80.62M | 82.12M | 150.23M | 65.69M | 58.87M | 48.27M | 36.10M | 55.61M | 54.42M | 46.58M | 45.86M |
| Net Income | 754.20M | 361.75M | 352.58M | 221.43M | 191.69M | 266.40M | 98.41M | 120.35M | 479.96M | 137.00M | 125.73M | 85.59M | 76.28M | 108.46M | 102.74M | 75.26M | 73.40M |
| Net Income Ratio | 20.81% | 10.59% | 11.29% | 8.99% | 6.02% | 8.52% | 3.42% | 3.97% | 14.96% | 4.27% | 4.34% | 3.26% | 3.30% | 4.96% | 5.06% | 4.09% | 4.64% |
| EPS | 132.15 | 63.39 | 61.78 | 38.80 | 33.59 | 46.68 | 17.24 | 27.96 | 84.10 | 24.01 | 22.03 | 15.00 | 13.37 | 19.00 | 18.00 | 13.19 | 12.86 |
| EPS Diluted | 132.15 | 63.39 | 61.78 | 38.80 | 33.59 | 46.68 | 17.24 | 27.96 | 84.10 | 24.01 | 22.03 | 15.00 | 13.37 | 19.00 | 18.00 | 13.19 | 12.86 |
| Weighted Avg Shares Out | 5.71M | 5.71M | 5.71M | 5.71M | 5.71M | 5.71M | 5.71M | 5.71M | 5.71M | 5.71M | 5.71M | 5.71M | 5.71M | 5.71M | 5.71M | 5.71M | 5.71M |
| Weighted Avg Shares Out (Dil) | 5.71M | 5.71M | 5.71M | 5.71M | 5.71M | 5.71M | 5.71M | 5.71M | 5.71M | 5.71M | 5.71M | 5.71M | 5.71M | 5.71M | 5.71M | 5.71M | 5.71M |
Source: https://incomestatements.info
Category: Stock Reports